|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.12 HKD | -1.50% |
|
-1.25% | -9.50% |
| 02-10 | New purchases in the Asia-Pacific Investor portfolio |  |
| 01-26 | Jefferies Adjusts Giant Biogene's Price Target to HK$50 From HK$55, Keeps at Buy | MT |
| Capitalization | 28.49B 32.47B 4.15B 3.6B 3.25B 3.11B 5.65B 383B 5.85B 38.72B 15.38B 183B 15.57B 15.23B 660B | P/E ratio 2025 * |
13.6x | P/E ratio 2026 * | 12x |
|---|---|---|---|---|---|
| Enterprise value | 22.51B 25.65B 3.28B 2.84B 2.57B 2.45B 4.46B 303B 4.62B 30.59B 12.15B 145B 12.3B 12.04B 522B | EV / Sales 2025 * |
3.8x | EV / Sales 2026 * | 3.13x |
| Free-Float |
42.68% | Yield 2025 * |
3.98% | Yield 2026 * | 4.12% |
| 1 day | -1.50% | ||
| 1 week | -1.25% | ||
| Current month | -5.64% | ||
| 1 month | -10.04% | ||
| 3 months | -12.80% | ||
| 6 months | -52.27% | ||
| Current year | -9.50% |
| 1 week | 29.52 |  | 31.24 |
| 1 month | 28.96 | | 34.48 |
| Current year | 28.96 | | 38 |
| 1 year | 28.96 | | 87.1 |
| 3 years | 28.4 | | 87.1 |
| 5 years | 24.3 | | 87.1 |
| 10 years | 24.3 | | 87.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Ya Yan
CEO | Chief Executive Officer | 59 | 2022-04-20 |
Hui Juan Zhang
DFI | Director of Finance/CFO | 39 | 2022-04-20 |
Yu Bo Yan
SEC | Corporate Secretary | 30 | 2018-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Jian Ya Yan
CHM | Chairman | 59 | 2022-04-20 |
Juan Ye
BRD | Director/Board Member | 55 | 2021-11-29 |
Jin Huang
BRD | Director/Board Member | 67 | 2022-10-05 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.50% | -1.25% | -56.76% | -38.97% | 4.15B | |
| -1.84% | -2.27% | -10.61% | +9.70% | 356B | |
| -0.38% | -4.52% | -6.37% | +5.46% | 142B | |
| -1.85% | -5.09% | -3.16% | +23.33% | 71.83B | |
| -1.13% | -5.24% | -2.55% | -13.33% | 60.58B | |
| -1.47% | -4.71% | -24.62% | - | 33.83B | |
| -7.92% | -12.08% | +26.87% | -64.31% | 33.11B | |
| -0.33% | -4.51% | -41.98% | -29.44% | 20B | |
| +1.04% | -1.06% | -13.40% | -5.57% | 19.1B | |
| -3.58% | -7.07% | +0.85% | +14.84% | 12.11B | |
| Average | -1.90% | -4.10% | -13.17% | -10.92% | 75.26B | |
| Weighted average by Cap. | -1.67% | -3.78% | -8.41% | +3.19% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.92B 6.74B 862M 748M 676M 645M 1.17B 79.56B 1.21B 8.04B 3.19B 38.01B 3.23B 3.16B 137B | 6.89B 7.85B 1B 870M 787M 751M 1.37B 92.63B 1.41B 9.37B 3.72B 44.26B 3.77B 3.68B 160B |
| Net income | 2.12B 2.41B 308M 268M 242M 231M 420M 28.48B 435M 2.88B 1.14B 13.61B 1.16B 1.13B 49.11B | 2.4B 2.74B 350M 304M 274M 262M 477M 32.31B 493M 3.27B 1.3B 15.44B 1.31B 1.29B 55.72B |
| Net Debt | -5.98B -6.82B -871M -755M -683M -652M -1.19B -80.4B -1.23B -8.13B -3.23B -38.41B -3.27B -3.2B -139B | -6.9B -7.86B -1B -871M -788M -752M -1.37B -92.71B -1.42B -9.37B -3.72B -44.3B -3.77B -3.69B -160B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-12 | 30.12 $ | -1.50% | 890,000 |
| 26-03-12 | 30.58 $ | -0.13% | 2,685,480 |
| 26-03-11 | 30.62 $ | -1.35% | 3,568,000 |
| 26-03-10 | 31.04 $ | +1.50% | 2,834,000 |
| 26-03-09 | 30.58 $ | +0.26% | 4,333,110 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 2367 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition